InspireMD
NSPR
35 hedge funds and large institutions have $34.7M invested in InspireMD in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
17% more funds holding
Funds holding: 30 → 35 (+5)
4% more capital invested
Capital invested by funds: $33.4M → $34.7M (+$1.34M)
5.23% less ownership
Funds ownership: 48.74% → 43.51% (-5.2%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.82M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$896K |
| 3 |
HA
Huntleigh Advisors
St. Louis,
Missouri
|
+$332K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$97.9K |
| 5 |
DIA
Dana Investment Advisors
Waukesha,
Wisconsin
|
+$85.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.22M |
| 2 |
Millennium Management
New York
|
-$889K |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$625K |
| 4 |
Morgan Stanley
New York
|
-$150K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$8.87K |
NSPR Hedge Fund Activity: Q1 2025 in Review
35 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2025, worth a combined $34.7M — up 4% from $33.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NSPR positions and 1 closed out — a net gain of 6 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $1.82M. The largest seller was Soleus Capital Management, cutting an estimated $1.22M.
- 35 institutional investors held InspireMD (NSPR) as of Q1 2025, up from 30 in Q4 2024.
- Funds reported $34.7M of InspireMD stock for Q1 2025, up 4% quarter-over-quarter.
- 7 funds opened new InspireMD positions in Q1 2025 and 1 closed out, a net change of +6 holders.
- The largest InspireMD buyer in Q1 2025 was Nantahala Capital Management, an estimated $1.82M added.
- The largest InspireMD seller in Q1 2025 was Soleus Capital Management, an estimated $1.22M sold.
Based on aggregated 13F filings for Q1 2025.